Indonesia approves emergency use of China's mRNA COVID-19 vaccine
STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine
DATELINE: Oct. 1, 2022
LENGTH: 0:01:17
LOCATION: Jakarta
CATEGORY: HEALTH/MEDICINE
SHOTLIST:
1. STANDUP (English): SUN LEI, Xinhua correspondent
2. various of press release
3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM)
4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia
5. various of mRNA vaccine
6. various of BPOM
STORYLINE:
The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies.
STANDUP (English): SUN LEI, Xinhua correspondent
"The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose."
AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog
- Product Code
- ILEA001022455
- Registered date
- 2022/10/01 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 82.05(MB)*
*File size when opened in Photoshop, etc.